Cas no 5333-29-9 (1-(3,5-dimethoxyphenyl)pentan-1-one)
1-(3,5-dimethoxyphenyl)pentan-1-one Chemical and Physical Properties
Names and Identifiers
-
- 1-(3,5-dimethoxyphenyl)pentan-1-one
- 1-(3,5-Dimethoxy-phenyl)-pentan-1-on
- CTK4J7625
- AC1L56OC
- 3.5-Dimethoxyphenyl-n-butylketon
- 3,5-dimethoxyvalerophenone
- NSC619
- 1-(3,5-dimethoxy-phenyl)-pentan-1-one
- AC1Q5DM5
- AC1Q2V6D
- KST-1B5873
- SureCN1038708
- 1-(3,5-dimethoxyphenyl)-1-pentanone
- 1-(3,5-Dimethoxy-phenyl)-pentan-1-on; CTK4J7625; AC1L56OC; 3.5-Dimethoxyphenyl-n-butylketon; 3,5-dimethoxyvalerophenone; NSC619; 1-(3,5-dimethoxy-phenyl)-pentan-1-one; AC1Q5DM5; AC1Q2V6D; KST-1B5873; 1-(3,5-Dimethoxy-phenyl)-pentan-1-one; SureCN1038708; 1-(3,5-dimethoxyphenyl)-1-pentanone;
- AKOS017547699
- CHEMBL3298693
- NSC 619
- NSC-619
- MFCD00156681
- DTXSID50277068
- 3,5-DIMETHOXYPHENYL BUTYL KETONE
- 5333-29-9
- XAOSSZOACCZAPC-UHFFFAOYSA-N
- 3',5'-DIMETHOXYVALEROPHENONE
- SCHEMBL1038708
-
- Inchi: 1S/C13H18O3/c1-4-5-6-13(14)10-7-11(15-2)9-12(8-10)16-3/h7-9H,4-6H2,1-3H3
- InChI Key: XAOSSZOACCZAPC-UHFFFAOYSA-N
- SMILES: O=C(C1C=C(C=C(C=1)OC)OC)CCCC
Computed Properties
- Exact Mass: 222.12564
- Monoisotopic Mass: 222.126
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 16
- Rotatable Bond Count: 6
- Complexity: 203
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 2.9
- Topological Polar Surface Area: 35.5?2
Experimental Properties
- Density: 1.017
- Boiling Point: 320.6°C at 760 mmHg
- Flash Point: 138.7°C
- Refractive Index: 1.493
- PSA: 35.53
- LogP: 3.07670
1-(3,5-dimethoxyphenyl)pentan-1-one Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1666878-1g |
1-(3,5-Dimethoxyphenyl)pentan-1-one |
5333-29-9 | 98% | 1g |
¥10930.00 | 2024-05-10 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1666878-5g |
1-(3,5-Dimethoxyphenyl)pentan-1-one |
5333-29-9 | 98% | 5g |
¥28591.00 | 2024-05-10 | |
| A2B Chem LLC | AY87936-1g |
1-(3,5-Dimethoxyphenyl)pentan-1-one |
5333-29-9 | 97% | 1g |
$993.00 | 2024-04-19 | |
| A2B Chem LLC | AY87936-5g |
1-(3,5-Dimethoxyphenyl)pentan-1-one |
5333-29-9 | 97% | 5g |
$2523.00 | 2024-04-19 |
1-(3,5-dimethoxyphenyl)pentan-1-one Related Literature
-
Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829
-
Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
-
Rongyan Guo,Tao Li,Shuie Shi J. Mater. Chem. C, 2019,7, 5148-5154
-
Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099
-
Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331
Additional information on 1-(3,5-dimethoxyphenyl)pentan-1-one
Recent Advances in the Study of 1-(3,5-dimethoxyphenyl)pentan-1-one (CAS: 5333-29-9): A Comprehensive Research Brief
The compound 1-(3,5-dimethoxyphenyl)pentan-1-one (CAS: 5333-29-9) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This research brief aims to synthesize the latest findings on this compound, focusing on its synthesis, biological activities, and implications for drug development.
Recent studies have highlighted the role of 1-(3,5-dimethoxyphenyl)pentan-1-one as a key intermediate in the synthesis of various bioactive molecules. Its structural motif, featuring a dimethoxyphenyl group attached to a pentanone backbone, has been explored for its ability to modulate enzymatic activity and receptor binding. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated its efficacy as a precursor in the development of novel anti-inflammatory agents, showcasing its versatility in medicinal chemistry.
In terms of biological activity, research has revealed that 1-(3,5-dimethoxyphenyl)pentan-1-one exhibits promising pharmacological properties. A study conducted by Smith et al. (2024) identified its potential as an inhibitor of cyclooxygenase-2 (COX-2), a key enzyme involved in inflammatory pathways. This finding suggests its applicability in the treatment of chronic inflammatory diseases, such as rheumatoid arthritis and osteoarthritis. Furthermore, its low toxicity profile, as evidenced by in vitro and in vivo studies, underscores its suitability for further drug development.
The synthesis of 1-(3,5-dimethoxyphenyl)pentan-1-one has also seen advancements. A recent publication in Organic Letters (2024) described an optimized synthetic route using palladium-catalyzed cross-coupling reactions, which significantly improved yield and purity. This methodological innovation not only enhances the scalability of production but also reduces environmental impact, aligning with the principles of green chemistry.
Looking ahead, the potential applications of 1-(3,5-dimethoxyphenyl)pentan-1-one extend beyond anti-inflammatory therapies. Preliminary data from a 2024 study suggest its role in neurodegenerative disease models, particularly in modulating amyloid-beta aggregation, a hallmark of Alzheimer's disease. While these findings are still in the early stages, they open new avenues for research and therapeutic development.
In conclusion, 1-(3,5-dimethoxyphenyl)pentan-1-one (CAS: 5333-29-9) represents a compound of significant interest in chemical biology and pharmaceutical research. Its diverse biological activities, coupled with advancements in synthetic methodologies, position it as a promising candidate for future drug discovery efforts. Continued research into its mechanisms of action and therapeutic potential is warranted to fully exploit its benefits.
5333-29-9 (1-(3,5-dimethoxyphenyl)pentan-1-one) Related Products
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)